Isolation of fibroblast growth factor
AssigneeThe Salk Institute for Biological Studies
InventorsDenis Gospodarowicz, Andrew Baird, Peter Bohlen
Life of this patent
Estimating the term…
Abstract
Basic Fibroblast Growth Factor (FGF) is substantially purified by the employment of affinity chromatography using heparin-linked support material. Described is a simplified three step procedure for extracting basic FGF from either mammalian brain or mammalian pituitary tissue. Salt precipitation, e.g., with ammonium sulfate is used to provide a partially purified precipitate that is then subjected to ion-exchange chromatography, e.g., using a Carboxymethyl-Sephadex column. Substantially pure basic FGF fractions are then obtained by fractionating the further partially purified fractions using affinity chromatography on a heparin-linked support e.g., Heparin-Sepharose.
Claims10
A method for separating basic fibroblast growth factor (bFGF) from a biological sample, said method comprising the steps of:
- binding bFGF in the biological sample to heparin linked to an insoluble support;
- eluting bFGF from said linked heparin by gradient fractionation;
- and selecting for fractions capable of inducing proliferation of vascular endothelial cells in vitro.
Dependencies are inferred from the claim text.